Clinical Practice Guidelines for Prostate Cancer

Abstract

Get full access to this article

View all access options for this article.

References

Parker

S.L.

, Tong

, Bolden

Cancer statistics, 1996. CA Cancer J Clin. 1996; 46: 5–27.

Scardino

P.T.

, Weaver

, Hudson

M.A.

Early detection of prostate cancer. Hum Pathol. 1992; 23: 211–222.

Cooner

W.H.

, Mosley

B.R.

, Rutherford

C.L.

Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990; 1146–1154.

Babaian

R.J.

, Dinney

C.P.

, Ramirez

E.I.

Diagnostic testing for prostate cancer detection: less is best. Urology. 1993; 41: 421–425.

Ruckle

H.C.

, Klee

G.G.

, Oesterling

J.E.

Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc. 1994; 69: 59–68.

Catalona

W.J.

, Smith

D.S.

, Ratliff

T.L.

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991; 324: 1156–1161.

Brawer

M.K.

, Chetner

M.P.

, Beatie

Screening for prostatic carcinoma with prostate specific antigen. J Urol. 1992; 147: 841–845.

Oesterling

J.E.

, Jacobsen

S.J.

, Chute

C.G.

Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA. 1993; 270: 860–864.

Middleton

R.G.

, Thompson

I.M.

, Austenfeld

M.S.

Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. J Urol. 1995; 154: 2144–2148.

10.

Blasko

J.C.

, Wallner

, Grimm

P.D.

Prostate specific antigen based disease control following ultrasound guided [125]iodine implantation for stage T1/T2 prostatic carcinoma. J Urol. 1995; 154: 1096–1099.

11.

Chodak

G.W.

, Thisted

R.A.

, Gerber

G.S.

Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994; 330: 242–248.